Ginkgo biloba extract for mild cognitive impairment
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with mild cognitive impairment (MCI).
- Your MoCA score is between 19 and 25.
- You can still manage your daily activities (like cooking, shopping, and handling finances) on your own.
- You do not have other serious medical conditions such as active cancer or severe heart/lung disease.
- You are not allergic to any ingredient in the study medication.
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
This study tests whether a natural compound called genistein (found in soy) can improve memory and thinking in people with mild cognitive impairment who are at risk for Alzheimer's disease. You'd take genistein as a supplement, and the study would see if it helps slow down further decline.
This study tests an experimental tablet called RP902 for people with mild cognitive impairment (early memory and thinking problems). The goal is to see if it can safely help slow down memory decline.
This trial studies whether Ginkgo biloba, a natural supplement, can affect certain blood markers in people with mild cognitive impairment (MCI). It may help show how the supplement works in the body and whether it could be a helpful option for early memory problems.
This trial tests whether adding ginkgo biloba extract tablets to standard stroke care helps improve memory and thinking in people who had a mild stroke. You may join if you are 55 or older, had a mild stroke in the last 1 to 2 weeks, and now have some cognitive difficulties.
This trial studies EGb 761 to see if it can improve symptoms in people with mild cognitive impairment (early memory/thinking changes) who also have signs of brain blood vessel disease. It may help by targeting the brain changes seen on scans.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.